Enallylpropymal

Enallylpropymal
Clinical data
Other names	Enallylpropymal
ATC code	none;
Identifiers
	IUPAC name (RS)-1-Methyl-5-allyl-5-isopropyl-1,3-diazinane-2,4,6-trione;
CAS Number	1861-21-8 ;
PubChem CID	95636;
ChemSpider	86329;
UNII	17BT2X209M;
CompTox Dashboard (EPA)	DTXSID40871852 ;
ECHA InfoCard	100.015.876
Chemical and physical data
Formula	C11H16N2O3
Molar mass	224.260 g·mol−1
3D model (JSmol)	Interactive image;
Chirality	Racemic mixture
	SMILES O=C1NC(=O)N(C)C(=O)C1(C(C)C)CC=C;
	InChI InChI=1S/C11H16N2O3/c1-5-6-11(7(2)3)8(14)12-10(16)13(4)9(11)15/h5,7H,1,6H2,2-4H3,(H,12,14,16); Key:AXJXURWWUFZZKN-UHFFFAOYSA-N;
	(verify)

Enallylpropymal (Narconumal) is a barbiturate derivative developed by Hoffman la Roche in the 1930s.^[1] It has sedative and hypnotic effects and is considered to have a moderate abuse potential.^[2]

References

^ US 2072829, Schnider O, "N-Methyl-5,5-allylisopropylbarbituric acid", issued 2 March 1937, assigned to Hoffmann-La Roche Inc.
^ Eddy NB, Halbach H, Isbell H, Seevers MH (1965). "Drug dependence: its significance and characteristics". Bulletin of the World Health Organization. 32 (5): 721–33. PMC 2555251. PMID 5294186.

This sedative-related article is a stub. You can help Wikipedia by expanding it.

[1] US 2072829, Schnider O, "N-Methyl-5,5-allylisopropylbarbituric acid", issued 2 March 1937, assigned to Hoffmann-La Roche Inc.

[pmid5294186-2] Eddy NB, Halbach H, Isbell H, Seevers MH (1965). "Drug dependence: its significance and characteristics". Bulletin of the World Health Organization. 32 (5): 721–33. PMC 2555251. PMID 5294186.

[1]

[2]